Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

1.

High Medication Adherence During Periconception Periods Among HIV-1-Uninfected Women Participating in a Clinical Trial of Antiretroviral Pre-exposure Prophylaxis.

Matthews LT, Heffron R, Mugo NR, Cohen CR, Hendrix CW, Celum C, Bangsberg DR, Baeten JM; Partners PrEP Study Team.

J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):91-7. doi: 10.1097/QAI.0000000000000246.

PMID:
25118795
[PubMed - in process]
Free PMC Article
2.

Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trial.

Mugo NR, Hong T, Celum C, Donnell D, Bukusi EA, John-Stewart G, Wangisi J, Were E, Heffron R, Matthews LT, Morrison S, Ngure K, Baeten JM; Partners PrEP Study Team.

JAMA. 2014 Jul 23-30;312(4):362-71. doi: 10.1001/jama.2014.8735.

PMID:
25038355
[PubMed - indexed for MEDLINE]
3.

Mannose-binding lectin and ficolin-2 do not influence humoral immune response to hepatitis B vaccine.

Osthoff M, Irungu E, Ngure K, Mugo N, Thomas KK, Baeten JM, Eisen DP.

Vaccine. 2014 Aug 20;32(37):4772-7. doi: 10.1016/j.vaccine.2014.06.023. Epub 2014 Jul 10.

PMID:
25024112
[PubMed - in process]
4.

Daily oral tenofovir and emtricitabine-tenofovir preexposure prophylaxis reduces herpes simplex virus type 2 acquisition among heterosexual HIV-1-uninfected men and women: a subgroup analysis of a randomized trial.

Celum C, Morrow RA, Donnell D, Hong T, Hendrix CW, Thomas KK, Fife KH, Nakku-Joloba E, Mujugira A, Baeten JM; Partners PrEP Study Team.

Ann Intern Med. 2014 Jul 1;161(1):11-9. doi: 10.7326/M13-2471.

PMID:
24979446
[PubMed - indexed for MEDLINE]
5.

Preferences for Daily or Intermittent Pre-exposure Prophylaxis Regimens and Ability to Anticipate Sex Among HIV Uninfected Members of Kenyan HIV Serodiscordant Couples.

Roberts ST, Heffron R, Ngure K, Celum C, Kurth A, Curran K, Mugo N, Baeten JM.

AIDS Behav. 2014 Sep;18(9):1701-11. doi: 10.1007/s10461-014-0804-1.

PMID:
24871870
[PubMed - in process]
6.

An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in Uganda.

Psaros C, Haberer JE, Katabira E, Ronald A, Tumwesigye E, Campbell JD, Wangisi J, Mugwanya K, Kintu A, Enyakoit M, Thomas KK, Donnell D, Krows M, Kidoguchi L, Ware N, Baeten JM, Celum C, Bangsberg DR, Safren SA.

J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):522-9. doi: 10.1097/QAI.0000000000000212.

PMID:
24853311
[PubMed - indexed for MEDLINE]
7.

Successful discontinuation of the placebo arm and provision of an effective HIV prevention product after a positive interim efficacy result: the partners PrEP study experience.

Ndase P, Celum C, Campbell J, Bukusi E, Kiarie J, Katabira E, Mugo N, Tumwesigye E, Wangisi J, Were E, Brantley J, Donnell D, Baeten JM.

J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):206-12. doi: 10.1097/QAI.0000000000000141.

PMID:
24828268
[PubMed - indexed for MEDLINE]
8.

Delay of antiretroviral therapy initiation is common in East African HIV-infected individuals in serodiscordant partnerships.

Mujugira A, Celum C, Thomas KK, Farquhar C, Mugo N, Katabira E, Bukusi EA, Tumwesigye E, Baeten JM; Partners PrEP Study Team.

J Acquir Immune Defic Syndr. 2014 Aug 1;66(4):436-42. doi: 10.1097/QAI.0000000000000192.

PMID:
24798765
[PubMed - indexed for MEDLINE]
9.

Pre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraception.

Murnane PM, Heffron R, Ronald A, Bukusi EA, Donnell D, Mugo NR, Were E, Mujugira A, Kiarie J, Celum C, Baeten JM; Partners PrEP Study Team.

AIDS. 2014 Jul 31;28(12):1825-30. doi: 10.1097/QAD.0000000000000290.

PMID:
24785951
[PubMed - in process]
10.

HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention.

Donnell D, Baeten JM, Bumpus NN, Brantley J, Bangsberg DR, Haberer JE, Mujugira A, Mugo N, Ndase P, Hendrix C, Celum C.

J Acquir Immune Defic Syndr. 2014 Jul 1;66(3):340-8. doi: 10.1097/QAI.0000000000000172.

PMID:
24784763
[PubMed - in process]
Free PMC Article
11.

My intention was a child but I was very afraid: fertility intentions and HIV risk perceptions among HIV-serodiscordant couples experiencing pregnancy in Kenya.

Ngure K, Baeten JM, Mugo N, Curran K, Vusha S, Heffron R, Celum C, Shell-Duncan B.

AIDS Care. 2014;26(10):1283-7. doi: 10.1080/09540121.2014.911808. Epub 2014 Apr 29.

PMID:
24779445
[PubMed - in process]
12.

Pre-exposure prophylaxis to intensify the fight against HIV.

Baeten JM, Heffron R.

Lancet Infect Dis. 2014 Jun;14(6):443-5. doi: 10.1016/S1473-3099(14)70070-2. Epub 2014 Mar 7. No abstract available.

PMID:
24613083
[PubMed - indexed for MEDLINE]
13.

Unreported antiretroviral use by HIV-1-infected participants enrolling in a prospective research study.

Kahle EM, Kashuba A, Baeten JM, Fife KH, Celum C, Mujugira A, Essex M, De Bruyn G, Wald A, Donnell D, John-Stewart G, Delany-Moretlwe S, Mugo NR, Farquhar C, Lingappa JR; Partners in Prevention HSVHIV Transmission Study Team.

J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):e90-4. doi: 10.1097/QAI.0b013e3182a2db02. No abstract available.

PMID:
24442233
[PubMed - indexed for MEDLINE]
14.

A prospective study of the effect of pregnancy on CD4 counts and plasma HIV-1 RNA concentrations of antiretroviral-naive HIV-1-infected women.

Heffron R, Donnell D, Kiarie J, Rees H, Ngure K, Mugo N, Were E, Celum C, Baeten JM; Partners in Prevention HSVHIV Transmission Study.

J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):231-6. doi: 10.1097/QAI.0000000000000013.

PMID:
24442226
[PubMed - indexed for MEDLINE]
15.

Enhanced and efficient detection of virus-driven cytokine expression by human NK and T cells.

Pattacini L, Murnane PM, Fluharty TR, Katabira E, De Rosa SC, Baeten JM, Lund JM.

J Virol Methods. 2014 Apr;199:17-24. doi: 10.1016/j.jviromet.2014.01.003. Epub 2014 Jan 10.

PMID:
24418500
[PubMed - in process]
16.

HIV-1 subtype C is not associated with higher risk of heterosexual HIV-1 transmission: a multinational study among HIV-1 serodiscordant couples.

Kahle E, Campbell M, Lingappa J, Donnell D, Celum C, Ondondo R, Mujugira A, Fife K, Mugo N, Kapiga S, Mullins JI, Baeten JM; Partners in Prevention HSVHIV Transmission Study Team.

AIDS. 2014 Jan 14;28(2):235-43. doi: 10.1097/QAD.0000000000000024.

PMID:
24413311
[PubMed - indexed for MEDLINE]
17.

'If I am given antiretrovirals I will think I am nearing the grave': Kenyan HIV serodiscordant couples' attitudes regarding early initiation of antiretroviral therapy.

Curran K, Ngure K, Shell-Duncan B, Vusha S, Mugo NR, Heffron R, Celum C, Baeten JM.

AIDS. 2014 Jan 14;28(2):227-33. doi: 10.1097/QAD.0000000000000025.

PMID:
24413310
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Systemic cytokine levels show limited correlation with risk of HIV-1 acquisition.

Lehman DA, Ronen K, Blish CA, Baeten JM, Jalalian-Lechak Z, Jaoko W, Mandaliya K, Richardson BA, McClelland RS, Overbaugh J.

J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):135-9. doi: 10.1097/QAI.0000000000000104.

PMID:
24413043
[PubMed - indexed for MEDLINE]
19.

Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: subgroup analyses from a randomized trial.

Murnane PM, Celum C, Mugo N, Campbell JD, Donnell D, Bukusi E, Mujugira A, Tappero J, Kahle EM, Thomas KK, Baeten JM; Partners PrEP Study Team.

AIDS. 2013 Aug 24;27(13):2155-60. doi: 10.1097/QAD.0b013e3283629037.

PMID:
24384592
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Incident herpes simplex virus type 2 infection increases the risk of subsequent episodes of bacterial vaginosis.

Masese L, Baeten JM, Richardson BA, Bukusi E, John-Stewart G, Jaoko W, Shafi J, Kiarie J, McClelland RS.

J Infect Dis. 2014 Apr 1;209(7):1023-7. doi: 10.1093/infdis/jit634. Epub 2013 Nov 22.

PMID:
24273042
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk